Targeting PSMA revolutionizes the role of nuclear medicine in diagnosis and treatment of prostate cancer
Simple Summary Imaging plays a crucial role in the accurate staging of prostate cancer.
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer cells, and …
Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer cells, and …
Piflufolastat F 18: diagnostic first approval
SJ Keam - Molecular Diagnosis & Therapy, 2021 - Springer
Abstract Piflufolastat F 18 (PYLARIFY®) is an 18 F-labelled diagnostic imaging agent that
has been developed by Progenics Pharmaceuticals Inc., a Lantheus company, for positron …
has been developed by Progenics Pharmaceuticals Inc., a Lantheus company, for positron …
Management of patients with recurrent and metachronous oligometastatic prostate cancer in the era of PSMA PET
Simple Summary Prostate-specific membrane antigen positron emission tomography (PSMA
PET) is a modern imaging modality used in the management of patients with prostate cancer …
PET) is a modern imaging modality used in the management of patients with prostate cancer …
Detection of Biochemically Recurrent Prostate Cancer with [18F]DCFPyL PET/CT: An Updated Systematic Review and Meta-Analysis with a Focus on Correlations …
[18F] DCFPyL is increasingly used for prostate-specific membrane antigen (PSMA)
mediated imaging of men with biochemically recurrent prostate cancer (BRPCa). In this meta …
mediated imaging of men with biochemically recurrent prostate cancer (BRPCa). In this meta …
The impact of PSMA PET/CT imaging in prostate cancer radiation treatment
E Mena, L Lindenberg, P Choyke - Seminars in nuclear medicine, 2022 - Elsevier
Imaging of prostate cancer is rapidly evolving with the introduction of the novel prostate-
specific membrane antigen (PSMA)-targeted PET imaging tool for managing recurrent …
specific membrane antigen (PSMA)-targeted PET imaging tool for managing recurrent …
[HTML][HTML] Prostate-specific membrane antigen positron emission tomography/computed tomography is associated with improved oncological outcome in men treated …
D Meijer, WSC Eppinga, RM Mohede… - European urology …, 2022 - Elsevier
Background Radiolabeled prostate-specific membrane antigen (PSMA) positron emission
tomography/computed tomography (PET/CT) has shown superior diagnostic accuracy to …
tomography/computed tomography (PET/CT) has shown superior diagnostic accuracy to …
Effect of 18F-DCFPyL PET on changes in management of patients with prostate cancer: a systematic review and meta-analysis
H Wang, HM Zhu, GN Li, JN Dai, HX Huang… - Frontiers in …, 2024 - frontiersin.org
Purpose Prostate-specific membrane antigen (PSMA)-targeted imaging has gained
increasing interest in its application in prostate cancer lesion detection. Compared with …
increasing interest in its application in prostate cancer lesion detection. Compared with …
[HTML][HTML] Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical …
D Meijer, PJ van Leeuwen, WSC Eppinga… - European urology open …, 2024 - Elsevier
Background and objective Owing to the greater use of prostate-specific membrane antigen
(PSMA) positron emission tomography/computed tomography (PET/CT) in patients with …
(PSMA) positron emission tomography/computed tomography (PET/CT) in patients with …
[PDF][PDF] Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET. Cancers 2022, 14, 6194
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scans
have higher sensitivity and specificity for detecting lymph nodes or metastatic disease …
have higher sensitivity and specificity for detecting lymph nodes or metastatic disease …
18F-DCFPyL PET versus 18F-PSMA-1007 PET for the Detection of Prostate Cancer Biochemical Recurrence: A Systematic Review and Meta-Analysis
H Huo, A Gu, S Shen, S Wu, H Zhang, Z Chen, F Yang - 2023 - researchsquare.com
Purpose This systematic review and meta-analysis aimed to compare the ability of 18F-
DCFPyL positron emission tomography (PET) and 18F-PSMA-1007 PET to detect …
DCFPyL positron emission tomography (PET) and 18F-PSMA-1007 PET to detect …